18F-FDG PET/CT在食管癌评估中的作用。
The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
作者信息
Chowdhury F U, Bradley K M, Gleeson F V
机构信息
Department of Nuclear Medicine, Oxford Radcliffe Hospitals, Oxford, UK.
出版信息
Clin Radiol. 2008 Dec;63(12):1297-309. doi: 10.1016/j.crad.2008.05.010. Epub 2008 Aug 21.
Integrated positron-emission tomography/computed tomography (PET/CT) with 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG) is now established in the management of oncology patients. With increasing availability and a constantly advancing body of evidence, the role of FDG PET/CT in oesophageal cancer is set to expand to include initial staging, assessment of disease response, therapy planning, and detection of disease recurrence. This article reviews the utility of FDG PET/CT in the management of oesophageal carcinoma, discussing its role and limitations in the imaging of these patients.
采用2-[氟-18]氟-2-脱氧-D-葡萄糖（FDG）的一体化正电子发射断层扫描/计算机断层扫描（PET/CT）现已应用于肿瘤患者的管理。随着其可及性的提高和证据的不断积累，FDG PET/CT在食管癌中的作用将扩大到包括初始分期、疾病反应评估、治疗规划以及疾病复发检测。本文综述了FDG PET/CT在食管癌管理中的应用，讨论了其在这些患者成像中的作用和局限性。
Zotero 插件